How many 8-K filings has Pulmonx Corp filed?

Pulmonx Corp (LUNG) has 14 8-K (Current Event Report) filings on record, spanning Feb 2024 to Apr 2026.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Pulmonx Corp 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Pulmonx Corp 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Pulmonx Corp (LUNG) — 8-K Filings

All 8-K filings from Pulmonx Corp. Browse 14 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (14)

8-K Filing — Apr 29, 2026
8-K Filing — Nov 12, 2025
Boston Scientific to Acquire Pulmonx for $3.1 Billion — Oct 27, 2025 Risk: medium
Pulmonx Corp. announced on October 21, 2025, that it has entered into a definitive agreement to be acquired by an affiliate of Boston Scientific Corporation for
Pulmonx Corp Files 8-K on Operations — Jul 30, 2025 Risk: low
Pulmonx Corporation filed an 8-K on July 30, 2025, to report on its results of operations and financial condition. The filing does not contain specific financia
Pulmonx Corp Files 8-K on Security Holder Vote Matters — May 23, 2025 Risk: low
Pulmonx Corporation filed an 8-K on May 23, 2025, reporting an event on May 22, 2025, related to the submission of matters to a vote of security holders. The fi
Pulmonx Corp Files 8-K on Financial Condition — Apr 30, 2025 Risk: low
Pulmonx Corporation filed an 8-K on April 30, 2025, to report on its results of operations and financial condition. The filing does not contain specific financi
Pulmonx Corp Files 8-K on Financial Condition — Feb 19, 2025 Risk: low
Pulmonx Corporation filed an 8-K on February 19, 2025, to report on its Results of Operations and Financial Condition. The filing does not contain specific fina
Pulmonx Corp Files 8-K on Financials — Oct 30, 2024 Risk: low
Pulmonx Corporation filed an 8-K on October 30, 2024, to report on its results of operations and financial condition. The filing does not contain specific finan
Pulmonx Corp Files 8-K on Financial Condition — Jul 31, 2024 Risk: low
Pulmonx Corporation filed an 8-K on July 31, 2024, to report on its Results of Operations and Financial Condition. The filing does not contain specific financia
Pulmonx Corp Files 8-K for Material Agreement — May 23, 2024 Risk: medium
On May 23, 2024, Pulmonx Corporation filed an 8-K report. The filing primarily concerns the entry into a material definitive agreement and the filing of financi
Pulmonx Corp Files 8-K on Security Holder Vote — May 17, 2024 Risk: low
Pulmonx Corporation filed an 8-K on May 17, 2024, to report matters submitted to a vote of its security holders. The filing does not contain details about the s
Pulmonx Corp Files 8-K on Financial Condition — May 1, 2024 Risk: low
Pulmonx Corporation filed an 8-K on May 1, 2024, to report on its Results of Operations and Financial Condition. The filing does not contain specific financial
Pulmonx Appoints New Chief Medical Officer — Apr 2, 2024 Risk: low
Pulmonx Corporation announced on April 2, 2024, the appointment of Dr. Michael J. Zwick as Chief Medical Officer. Dr. Zwick previously served as Chief Medical O
Pulmonx Reports Officer Changes & Compensation on Feb 21 — Feb 21, 2024 Risk: medium
Pulmonx Corporation filed an 8-K on February 21, 2024, reporting on the departure or election of directors or certain officers and their compensatory arrangemen

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX